RECRUITING

Developing a Clinical Outcome Assessment for Opioid Craving

Study Overview

This clinical trial focuses on testing the efficacy of different digital interventions to promote re-engagement in cancer-related long-term follow-up care for adolescent and young adult (AYA) survivors of childhood cancer.

Description

The purpose of this study is to collect information about opioid craving so that the investigators can develop an opioid craving assessment to improve treatments for individuals with opioid use disorder. To collect this information, the investigators are recruiting individuals in treatment for opioid use disorder who will complete cue-induced opioid craving tasks where these individuals will: (1) look at pictures of neutral objects and touch neutral objects (e.g., water bottles or flashlights), (2) look at opioid-related images, and (3) look and touch opioid-related objects. Participants will then complete a one-on-one interview about the thoughts, feelings and physical sensations the participants experienced during the cue-induced craving session. Participants will also complete questionnaires and existing opioid craving assessments. Finally, participants will provide formal feedback about existing opioid craving assessments with cognitive interviews.

Official Title

Developing a Clinical Outcome Assessment for Opioid Craving

Quick Facts

Study Start:2022-03-03
Study Completion:2026-09-30
Study Type:Not specified
Phase:Not Applicable
Enrollment:Not specified
Status:RECRUITING

Study ID

NCT05109429

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Ages Eligible for Study:18 Years
Sexes Eligible for Study:ALL
Accepts Healthy Volunteers:Yes
Standard Ages:ADULT, OLDER_ADULT
Inclusion CriteriaExclusion Criteria
  1. * 18 years of age and older
  2. * Opioid-positive urine sample at admission visit (excluding individuals receiving Naltrexone).
  3. * Current opioid use disorder per Diagnostic Statistical Manual (DSM)-5
  4. * Currently in treatment for opioid use disorder
  1. * Being pregnant or breastfeeding, or may become pregnant during the trial
  2. * History of psychosis or mania or other serious psychiatric disorders assessed by the Mini International Neuropsychiatric Interview
  3. * Past 30-day suicidal behavior assessed by the Columbia Suicide Severity Rating Scale
  4. * Have circumstances that would interfere with study participation (e.g., impending jail).
  5. * Positive for illicit substances except opioids and cannabis
  6. * Current substance use disorder other than opioid or nicotine
  7. * Current intoxication

Contacts and Locations

Study Contact

Cecilia L Bergeria, PhD
CONTACT
410-550-1979
cberge21@jhmi.edu
Kelly Dunn, Ph.D., M.B.A.
CONTACT
410-550-2254
kdunn9@jhmi.edu

Principal Investigator

Cecilia L Bergeria, PhD
PRINCIPAL_INVESTIGATOR
Johns Hopkins University

Study Locations (Sites)

Behavioral Pharmacology Research Unit
Baltimore, Maryland, 21224
United States

Collaborators and Investigators

Sponsor: Johns Hopkins University

  • Cecilia L Bergeria, PhD, PRINCIPAL_INVESTIGATOR, Johns Hopkins University

Study Record Dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Registration Dates

Study Start Date2022-03-03
Study Completion Date2026-09-30

Study Record Updates

Study Start Date2022-03-03
Study Completion Date2026-09-30

Terms related to this study

Additional Relevant MeSH Terms

  • Opioid Craving
  • Opioid Use Disorder
  • Measure Development